Results for "Understanding Pharmaceutical Distribution"
HDA Statement on FDA's Proposed National Standards for Licensure of Distributors and 3PLs
The Healthcare Distribution Alliance (HDA) released the following statement on the U.S. Food and Drug Administration’s (FDA) proposed national licensure standards for distributors and third-party logistics providers (3PLs). HDA recently submitted public comments to FDA on the agency’s proposed standards, which are required to be established under the 2013 Drug Supply Chain Security Act (DSCSA).
HDA Appoints Kala Shankle Vice President of Regulatory Affairs
HDA announces the appointment of Kala Shankle as Vice President of Regulatory Affairs.
Greg Drew, RPh, of Value Drug Honored With 2022 Nexus Award for Lifetime Achievement
The HDA Research Foundation honors Greg Drew, RPh, President of Value Drug Company, with the 2022 Nexus Award for Lifetime Achievement. The Nexus Award, the healthcare distribution industry’s highest individual recognition, was presented last night at the 2022 Business and Leadership Conference in Orlando, Fla.
HDA To Convene Rx Supply Chain Professionals as Industry Closes in on Drug Supply Chain Security Act Implementation Deadline
The Healthcare Distribution Alliance (HDA) will host its annual Traceability Seminar, providing an opportunity for supply chain professionals to discuss Drug Supply Chain Security Act (DSCSA) implementation.